R&D Novel study designs for rare diseases Developing treatments for rare diseases poses many unique challenges that cannot be addressed by traditional study designs.
R&D Tech & Trials: Recruiting is hard, AI can make it easier Recruiting for clinical trials is hard… and expensive.
Patients 5 patient travel strategies to impact enrolment diversity in... According to the latest CISCRP report, “having to travel to the study clinic” is patients’ top-cited participation burden
R&D Clinical research is about trial and error Companies have been trying to expedite and optimise drug trials for ages.
News Phesi finds fifth of cancer trial sites recruit one patient Phesi, a global provider of patient-centric data analytics, has uncovered the urgent need for the clinical trials industry to address the issue of single-patient enrolment
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.